European Case Law Identifier: | ECLI:EP:BA:2014:T042812.20140626 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 26 June 2014 | ||||||||
Case number: | T 0428/12 | ||||||||
Application number: | 04786507.6 | ||||||||
IPC class: | C07F 5/02 A61K 31/69 A61P 35/00 |
||||||||
Language of proceedings: | EN | ||||||||
Distribution: | D | ||||||||
Download and more information: |
|
||||||||
Title of application: | PROTEASOME INHIBITORS AND METHODS OF USING THE SAME | ||||||||
Applicant name: | CEPHALON, INC. | ||||||||
Opponent name: | Millennium Pharmaceuticals, Inc. | ||||||||
Board: | 3.3.01 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: |
|
||||||||
Keywords: | Amendment occasioned by ground for opposition - amendments allowable (yes) Amendments - added subject-matter (no) Inventive step - (yes) |
||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t120428eu1.html
Date retrieved: 17 May 2021